Gamma delta (γδ) T cells are a type of innate-like T cell that possess dual anti-tumor activities, capable of directly eliminating tumor cells and acting as immunostimulatory cells to enhance the body’sRead More…
The trend in the field of cancer immunotherapy is the use of cancer vaccines. By using identified tumor antigens to stimulate the immune system, cancer vaccines can generate a specific immune responseRead More…
Recently, a research paper titled “Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine” was published in Cell Reports Medicine, a sub-journal of Cell.Read More…
Tumor vaccine is the use of tumor antigen to cause the body to create particular anti-tumor effect, activate the body’s own immune defense mechanism, and achieve the function of tumor therapy orRead More…
Vaccines have traditionally been used to prevent infectious diseases. However, the ability of this drug to induce and amplify antigen-specific immune responses has long been considered a potentially valuable tool for cancerRead More…
In the clinical trial of oncolytic vesicular stomatitis virus expressing interferon-β (VSV-IFN-β), a large group of patients initially achieved a preliminary response, but then the disease relapsed. A few days ago, inRead More…